As a key molecular component of this axis, HOPX could epigenetically inhibit SRF-dependent SNAIL transcription via the recruitment of HDAC2 and the enhancement of histone H3K9 deacetylation, which subsequently suppressed NPC progression. The gene discussed is HOPX; the disease is nasopharyngeal carcinoma.